266 related articles for article (PubMed ID: 11423853)
21. [Response to mycophenolate mofetil in a case of lupus nephropathy resistant to cyclophosphamide IV and cyclosporin A].
Navas-Parejo A; Espigares MJ; Alhosni A; García-Valdecasas J
Nefrologia; 2001; 21(5):516-7. PubMed ID: 11795027
[No Abstract] [Full Text] [Related]
22. Mycophenolate mofetil therapy for pediatric bullous pemphigoid.
Seminario-Vidal L; Sami N; Miller J; Theos A
Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437160
[TBL] [Abstract][Full Text] [Related]
23. Mycophenolate mofetil: a magic bullet for lupus?
McCune WJ; Riskalla MM
J Rheumatol; 2005 Jun; 32(6):967-70. PubMed ID: 15940751
[No Abstract] [Full Text] [Related]
24. Effect of mycophenolate mofetil on the white blood cell count and the frequency of infection in systemic lupus erythematosus.
Subedi A; Magder LS; Petri M
Rheumatol Int; 2015 Oct; 35(10):1687-92. PubMed ID: 25836768
[TBL] [Abstract][Full Text] [Related]
25. Brain diffuse large B-cell lymphoma in a systemic lupus erythematosus patient treated with immunosuppressive agents including mycophenolate mofetil.
Svobodova B; Hruskova Z; Rysava R; Tesar V
Lupus; 2011 Nov; 20(13):1452-4. PubMed ID: 21868432
[No Abstract] [Full Text] [Related]
26. A case of minimal change disease treated successfully with mycophenolate mofetil in a patient with systemic lupus erythematosus.
Hong YH; Yun DY; Jung YW; Oh MJ; Kim HJ; Lee CK
Korean J Intern Med; 2011 Dec; 26(4):470-3. PubMed ID: 22205851
[TBL] [Abstract][Full Text] [Related]
27. Mycophenolate mofetil and skin diseases.
Hartmann M; Enk A
Lupus; 2005; 14 Suppl 1():s58-63. PubMed ID: 15803935
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus.
Gammon B; Hansen C; Costner MI
J Am Acad Dermatol; 2011 Oct; 65(4):717-721.e2. PubMed ID: 21641078
[TBL] [Abstract][Full Text] [Related]
29. [Therapy of lupus nephritis with mycophenolate mofetil].
Celić D; Ilić T; Durdević-Mirković T; Mitić I; Milić B; Curić S
Med Pregl; 2007; 60 Suppl 2():124-7. PubMed ID: 18928177
[TBL] [Abstract][Full Text] [Related]
30. Non-transplant uses of mycophenolate mofetil.
Jayne D
Curr Opin Nephrol Hypertens; 1999 Sep; 8(5):563-7. PubMed ID: 10541218
[TBL] [Abstract][Full Text] [Related]
31. Controversies in Systemic Lupus Erythematosus: Are We Treating Our Patients Adequately?
Porta SV; Ugarte-Gil MF; García-de la Torre I; Bonfá E; Gómez-Puerta JA; Arnaud L; Cardiel MH; Alarcón GS; Pons-Estel BA; Pons-Estel G
J Clin Rheumatol; 2022 Mar; 28(2):e651-e658. PubMed ID: 34897194
[TBL] [Abstract][Full Text] [Related]
32. Mycophenolate mofetil treatment of myasthenia gravis.
Cahoon WD; Kockler DR
Ann Pharmacother; 2006 Feb; 40(2):295-8. PubMed ID: 16403848
[TBL] [Abstract][Full Text] [Related]
33. Mycophenolate mofetil: a new immunosuppressive approach. Successful treatment in a case of myasthenia gravis associated with incomplete lupus erythematosus syndrome and hepatitis C virus infection.
Caponnetto C; Rossi E; Primavera A
Eur Neurol; 2001; 46(1):53-4. PubMed ID: 11455187
[No Abstract] [Full Text] [Related]
34. The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosus.
Richez C; Richards RJ; Duffau P; Weitzner Z; Andry CD; Rifkin IR; Aprahamian T
PLoS One; 2013; 8(4):e61042. PubMed ID: 23577189
[TBL] [Abstract][Full Text] [Related]
35. Hypersensitivity to mycophenolate mofetil in systemic lupus erythematosus: diagnostic measures and successful desensitization.
Szyper-Kravitz M; Sheinberg P; Sidi Y; Schiffenbauer Y; Trubniykov E; Shoenfeld Y
Int Arch Allergy Immunol; 2005 Dec; 138(4):334-6. PubMed ID: 16224194
[TBL] [Abstract][Full Text] [Related]
36. First international meeting on mycophenolate mofetil: an advance in the treatment of lupus 27 April 2004, St Thomas' Hospital, London, UK.
Vasoo S
Lupus; 2004; 13(7):543-5. PubMed ID: 15352427
[No Abstract] [Full Text] [Related]
37. The effect of mycophenolate mofetil on patients with active non-renal SLE.
Moder KG; Amin S; Mazlumzadeh M; Crowson C; Ytterberg S
Clin Exp Rheumatol; 2007; 25(6):932. PubMed ID: 18173935
[No Abstract] [Full Text] [Related]
38. Childhood discoid lupus in identical twins.
Del Boz J; Martín T; Samaniego E; Vera A; Sanz A; Crespo V
Pediatr Dermatol; 2008; 25(6):648-9. PubMed ID: 19067880
[TBL] [Abstract][Full Text] [Related]
39. Linear childhood discoid lupus erythematosus following the lines of Blaschko: successfully treated with topical tacrolimus.
Kawachi Y; Taguchi S; Fujisawa Y; Furuta J; Nakamura Y; Ishii Y; Otsuka F
Pediatr Dermatol; 2011; 28(2):205-7. PubMed ID: 20825568
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil.
Ungprasert P; Chowdhary VR; Davis MD; Makol A
Lupus; 2016 Apr; 25(4):427-30. PubMed ID: 26537421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
